To add to the growing list of recent life science real estate developments in Greater Philadelphia, this week Scheer Partners shared that SkyREM, a real estate investor, owner, and developer with properties across the country, has big plans to convert Philly’s historic Quartermaster site into the Quartermaster Science + Technology Park. The $250 million commercial redevelopment project will include both wet and dry lab space catering to early-stage life science startups as well as more established companies.
Philadelphia-based Context Therapeutics reported that its clinical collaborator, Stemline Therapeutics, had its Orserdu (elacestrant) approved by the FDA. Stemline Therapeutics is a U.S.-based, wholly-owned subsidiary of Italy’s The Menarini Group.
West Conshohocken, Pa.-based Keystone, a commercial real estate development and investment company, is more than doubling lab space in Philadelphia’s Center City. The company recently announced the expansion of its laboratory space at The Curtis, adding 200,000 square feet to provide more than 325,000 square feet.
XyloCor Therapeutics, based in Wayne, Pa., recently announced its Phase I/II EXACT trial has wrapped the Phase II portion of the study. The trial was evaluating the company’s lead gene therapy candidate XC001 (encoberminogene rezmadenovic) in patients with refractory angina.
Despite its challenges, 2022 still proved to be an exciting year for life science real estate in the City of Brotherly Love. Companies announced various new projects throughout Philadelphia, targeting niches like university graduates and biomanufacturing. While experts say the city’s growth is due to slow down, it’s impossible not to acknowledge the leaps and bounds Philly has made recently.
Even as 2023 brings continued economic uncertainty, the Philly life sciences community has much to be optimistic about. Here are five companies whose potential 2023 achievements make them worthy of attention in the first half of the year.
Why It Pays to Buy Pre-owned Lab Equipment, Especially in This Economy What to look for, and how a one-stop shop like BaneBio can provide even more advantages By Alex [….]
Here’s what’s been happening Greater Philadelphia’s Life Science scene the week of January 23, 2023
Ahead of presentations at the 6th Annual DDR Inhibitors Summit in Boston this week, Oren Gilad, Ph.D., president and CEO of Aprea, and Eric Brown, Ph.D., Scientific Consultant to Aprea, member of the company’s Scientific Advisory Board, and Associate Professor of Cancer Biology at the University of Pennsylvania, took time out to speak with BioBuzz about the company and the significance of new target and biomarker identification in oncology research.
ennovation Works, the 23-acre University of Pennsylvania property just across the Schuylkill River from the core campus, has long been a site for innovation. Home to a ferry business in the 18th century, a paint company in the 19th century, and a DuPont chemical research facility for much of the 20th century, the space underwent a further transformation in 2016 with the establishment of the Pennovation Center, an incubator for science and technology startups, many of which have their origins within the University. Last year, the 65,000 square foot Pennovation Lab opened, offering larger lab spaces for companies outgrowing their previous locations.